Trade Mark Journal No.2025/026 27 June 2025
UK00004216978 10 June 2025 (5,42)
Mark 1

Mark 2

- Class 5
- Pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; Pharmaceutical preparations for the prevention of diseases of the nervous system; Pharmaceutical preparations for the prevention of disorders of the nervous system; Immunoassay reagents for medical use; Medical diagnostic reagents and assays for testing of body fluids; Diagnostic biomarker reagents for medical purposes; In vitro diagnostic preparations for medical use; Pharmaceuticals.
- Class 42
- Scientific research relating to biology; Scientific research in the field of genetics; Biotechnology research; Biological research, clinical research and medical research; Scientific research relating to genetics; Biotechnology research for determining the neuronal survival of molecules in animal models; Scientific research and development; Pharmaceutical research and development; Research in the field of gene therapy; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the pharmaceutical and biotechnology fields; Research and development for the pharmaceutical industry; Research relating to biotechnology.
CRUCIBLE THERAPEUTICS LIMITED